These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48 related articles for article (PubMed ID: 2234476)
21. [Endothelial dysfunction in scleroderma systematica: clinicopathogenetic correlations]. Volkov AV; Mach ES; Guseva NG Ter Arkh; 2008; 80(10):68-72. PubMed ID: 19105419 [TBL] [Abstract][Full Text] [Related]
22. The Münster Heart Study (PROCAM). Results of follow-up at 8 years. Assmann G; Cullen P; Schulte H Eur Heart J; 1998 Feb; 19 Suppl A():A2-11. PubMed ID: 9519336 [TBL] [Abstract][Full Text] [Related]
23. Cardiovascular risk factors and lipoprotein profile in French Canadians with premature CAD: impact of the National Cholesterol Education Program II. McNicoll S; Latour Y; Rondeau C; Bouthillier D; Davignon J; Genest J Can J Cardiol; 1995 Feb; 11(2):109-16. PubMed ID: 7866933 [TBL] [Abstract][Full Text] [Related]
24. [Cardiovascular risk factors in the region of Murcia, Spain]. Tormo Díaz MJ; Navarro Sánchez C; Chirlaque López MD; Pérez Flores D Rev Esp Salud Publica; 1997; 71(6):515-29. PubMed ID: 9477707 [TBL] [Abstract][Full Text] [Related]
25. Incidence of cardiovascular risk factors and complications before and after kidney transplantation. Fazelzadeh A; Mehdizadeh A; Ostovan MA; Raiss-Jalali GA Transplant Proc; 2006 Mar; 38(2):506-8. PubMed ID: 16549161 [TBL] [Abstract][Full Text] [Related]
26. [Relationship of fibrinogen with cardiovascular risk factors in healthy men from Maracaibo, Venezuela]. Campos G; Diez-Ewald M; Ryder E; Torres-Guerra E; Fernández V; Rivero F; Arocha-Piñango CL; Invest Clin; 2008 Sep; 49(3):341-51. PubMed ID: 18846775 [TBL] [Abstract][Full Text] [Related]
27. Twelve-year trends in cardiovascular disease risk factors in the Minnesota Heart Survey. Are socioeconomic differences widening? Iribarren C; Luepker RV; McGovern PG; Arnett DK; Blackburn H Arch Intern Med; 1997 Apr; 157(8):873-81. PubMed ID: 9129547 [TBL] [Abstract][Full Text] [Related]
28. Risk factors for cardiovascular disease in Sardinia from 1978 to 2001: a comparative study with Italian mainland. Muntoni S; Atzori L; Mereu R; Manca A; Satta G; Gentilini A; Bianco P; Baule A; Baule GM; Muntoni S Eur J Intern Med; 2009 Jul; 20(4):373-7. PubMed ID: 19524177 [TBL] [Abstract][Full Text] [Related]
29. First risk functions for prediction of coronary and cardiovascular disease incidence in the Gubbio Population Study. Menotti A; Lanti M; Puddu PE; Mancini M; Zanchetti A; Cirillo M; Vagnarelli OT Ital Heart J; 2000 Jun; 1(6):394-9. PubMed ID: 10929739 [TBL] [Abstract][Full Text] [Related]
30. Cardiovascular death in rheumatoid arthritis: a population-based study. Maradit-Kremers H; Nicola PJ; Crowson CS; Ballman KV; Gabriel SE Arthritis Rheum; 2005 Mar; 52(3):722-32. PubMed ID: 15751097 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and treatment of cardiovascular disease and traditional risk factors in Australian adults with renal insufficiency. Briganti EM; Kerr PG; Shaw JE; Zimmet PZ; Atkins RC Nephrology (Carlton); 2005 Feb; 10(1):40-7. PubMed ID: 15705181 [TBL] [Abstract][Full Text] [Related]
32. [Arterial stiffness in patients with systemic sclerosis]. Karoli NA; Rebrov AP Ter Arkh; 2011; 83(5):38-41. PubMed ID: 21780655 [TBL] [Abstract][Full Text] [Related]
33. Plasma or serum from patients with systemic sclerosis alters behaviour of normal erythrocytes. Kovacs IB; Rustin MH; Thomas RH; Ridler C; Sowemimo-Coker SO; Kirby JD Ann Rheum Dis; 1985 Jun; 44(6):395-8. PubMed ID: 4015202 [TBL] [Abstract][Full Text] [Related]
34. Comment on: The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study. Chen FY; Huo AP; Wei JC Rheumatology (Oxford); 2024 Aug; 63(8):e236. PubMed ID: 38262345 [No Abstract] [Full Text] [Related]
35. Comment on: The risk of major adverse cardiovascular events in patients with systemic sclerosis: a nationwide, population-based cohort study: Reply. Yen TH; Chen HH Rheumatology (Oxford); 2024 Aug; 63(8):e234-e235. PubMed ID: 38244564 [No Abstract] [Full Text] [Related]
36. [Cardiovascular involvement and relative risk factors in systemic sclerosis. Personal contribution]. Tulli D; Palermo R; Gasparini M; Ganzetti S; Balestra E; Conti V Minerva Med; 1990 Sep; 81(9):583-6. PubMed ID: 2234476 [TBL] [Abstract][Full Text] [Related]
37. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166 [TBL] [Abstract][Full Text] [Related]
38. Correlation of endostatin and tissue inhibitor of metalloproteinases 2 (TIMP2) serum levels with cardiovascular involvement in systemic sclerosis patients. Dziankowska-Bartkowiak B; Waszczykowska E; Zalewska A; Sysa-Jedrzejowska A Mediators Inflamm; 2005 Aug; 2005(3):144-9. PubMed ID: 16106100 [TBL] [Abstract][Full Text] [Related]
39. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy]. Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189 [TBL] [Abstract][Full Text] [Related]
40. [Evaluation of early cardiovascular involvement in patients with systemic sclerosis]. Wranicz JK; Strzondała M; Zielińska M; Cygankiewicz I; Ruta J; Dziankowska-Bartkowiak B; Sysa-Jedrzejowska A Przegl Lek; 2000; 57(7-8):389-92. PubMed ID: 11109311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]